Avian Bioreactor Systems: A Review
- 198 Downloads
Animal bioreactors are genetically modified animal systems that have the potential to reduce production cost, and improve production efficiency, of pharmaceutically relevant recombinant proteins. Several species including goats, cattle, rabbits, and avians have been genetically modified to secrete target proteins into milk, egg whites, blood, or other bodily fluids. There are several advantages associated with the use of avians as bioreactor systems. Avians have a short generation time, leading to the quick establishment of a transgenic line and high egg production. Transgenic avian systems allow for appropriate post-translational modification, as opposed to prokaryotic cell culture bioreactors, and have higher productivity than mammalian cell culture systems. Furthermore, recombinant proteins can be incorporated into egg whites and easily collected from the sterile environment of the egg. Magnum-specific expression of target genes has been achieved by use of the ovalbumin promoter, leading to a localization of the target protein into the avian egg. In this review, we discuss the current advancements, future potential, and limitations of avian bioreactor systems.
KeywordsBioreactor Avian Chicken Transgenic Ovalbumin Retroviral vector
The authors would like to acknowledge Erin Connell, Eugene Lee, and Michelle Milligan for their assistance in helping prepare this manuscript for submission.
The paper was written by RW and KL with help from EH. Figure and table were made by RW. KL oversaw the development of the paper. All authors have read and approve the final manuscript.
This work was partially supported by: (1) the United States Department of Agriculture National Institute of Food and Agriculture Grant (Project No. 2016-08413), and (2) the Ohio Agricultural Research and Development Center Research SEEDS funding (Project No. 2017-069).
Compliance with Ethical Standards
Conflict of interest
The authors of this paper declare no conflict of interest.
Research Involving Human Participants and/or Animals
This article does not contain any studies with human participants or animals performed by any of the authors.
- 1.Pham, V., & Phuc (2017). Medical biotechnology: Techniques and applications. In D. Barh, V. Azevedo (Eds.), Omics technologies and bio-engineering: Towards improving quality of life (Vol. 1, pp. 449–469). Amsterdam: Academic Press.Google Scholar
- 9.Maksimenko, O. G., Deykin, A. V., Khodarovich, Y. M., & Georgiev, P. G. (2013). Use of transgenic animals in biotechnology: Prospects and problems. Acta Naturae., 1, 33–46.Google Scholar
- 10.Kwon, M. S., Koo, B. C., Kim, D., Nam, Y. H., Cui, X.-S., Kim, N.-H., et al. (2018). Generation of transgenic chickens expressing the human erythropoietin (hEPO) gene in an oviduct-specific manner: Production of transgenic chicken eggs containing human erythropoietin in egg whites. PLoS ONE, 13, 5.Google Scholar
- 12.Editorial Staff. (2014). Rabbit milk Ruconest for hereditary angioedema. Nature Biotechnology, 32, 849.Google Scholar
- 20.Li, Z., Zeng, F., Meng, F., Xu, Z., Zhang, X., Huang, X., et al. (2014). Generation of transgenic pigs by cytoplasmic injection of piggyBac transposase-based pmGENIE-3 plasmids. Biology of Reproduction, 90, 5.Google Scholar
- 21.Ahn, J., Shin, S., Suh, Y., Park, J. Y., Hwang, S., & Lee, K. (2015). Identification of the avian RBP7 gene as a new adipose-specific gene and RBP7 promoter-driven GFP expression in adipose tissue of transgenic quail. PLoS ONE, 10, 4.Google Scholar
- 22.Woodfint, R. M., Chen, P. R., Ahn, J., Suh, Y., Hwang, S., Lee, S. S., et al. (2017). Identification of the MUC2 Promoter as a Strong Promoter for Intestinal Gene Expression through Generation of Transgenic Quail Expressing GFP in Gut Epithelial Cells. International Journal of Molecular Sciences, 18, 1.CrossRefGoogle Scholar
- 34.Macdonald, J., Taylor, L., Sherman, A., Kawakami, K., Takahashi, Y., Sang, H. M., et al. (2012). Efficient genetic modification and germ-line transmission of primordial germ cells using piggyBac and Tol2 transposons. Proceedings of the National Academy of Sciences, 109(23), 1466–1472.CrossRefGoogle Scholar
- 36.Pinkert, C. A. (2014). Transgenic animal technology: A laboratory handbook (3rd ed.). Amsterdam: Elsevier.Google Scholar
- 62.Cao, D., Wu, H., Li, Q., Sun, Y., Liu, T., Fei, J., et al. (2015). Expression of recombinant human lysozyme in egg whites of transgenic hens. PLoS ONE, 10, 2.Google Scholar
- 63.Liu, T., Wu, H., Cao, D., Li, Q., Zhang, Y., Li, N., et al. (2015). Oviduct-specific expression of human neutrophil defensin 4 in lentivirally generated transgenic chickens. PLoS ONE, 10, 5.Google Scholar
- 64.Schweers, L. A., Frank, D. E., Weigel, N. L., & Sanders, M. M. (1990). The steroid-dependent regulatory element in the ovalbumin gene does not function as a typical steroid response element. Journal of Biological Chemistry, 13, 7590–7595.Google Scholar
- 66.Rodriguez, A., Castro, F. O., Aguilar, A., Ramos, B., Del, B. D. G., Lleonart, R., et al. (1995). Expression of active human erythropoietin in the mammary gland of lactating transgenic mice and rabbits. Biological Research, 2, 141–153.Google Scholar
- 71.Yukiko, K., Yu, H., Atsuo, K., & Shin-ichi, H. (2014). Efficient generation of knock-in transgenic zebrafish carrying reporter/ driver genes by CRISPR/Cas9-mediated genome engineering. Scientific Reports, 4, 6545.Google Scholar
- 76.Bai, J., Li, J., & Mao, Q. (2013). Construction of a single lentiviral vector containing tetracycline-inducible Alb-uPA for transduction of uPA expression in murine hepatocytes. PLoS ONE, 8, 4.Google Scholar
- 77.National Research Council (US) Committee. (2002). Animal biotechnology: Science-based concerns. Washington, DC: National Academies Press.Google Scholar
- 78.Doran, T. J., Cooper, C. A., Jenkins, K. A., & Tizard, M. L. (2106). Advances in genetic engineering of the avian genome: “Realizing the promise”. Transgenic Research, 3, 307–319.Google Scholar